Abstract:Although increased dietary fructose consumption is associated with metabolic impairments, the mechanisms and regulation of intestinal fructose absorption are poorly understood. GLUT5 is considered to be the main intestinal fructose transporter. Other GLUT family members, such as GLUT7 and GLUT9 are also expressed in the intestine and were shown to transport fructose and glucose. A conserved isoleucine-containing motif (NXI) was proposed to be essential for fructose transport capacity of GLUT7 and GLUT9 but als… Show more
“…For all cloning procedures we used the vector pMXs with human GLUT5-GFP or GLUT7-GFP (GLUT7: NM_207420.2, GLUT5: NM_003039.2) insert as described elsewhere [9]. In the first round, we divided GLUT5 into 26 fragments covering the complete protein sequence and constructed GLUT5-GLUT7-GFP chimeras by overlap extension PCR.…”
Section: Methodsmentioning
confidence: 99%
“…Although their protein sequence is approximately 60 % identical, the transport characteristics are different. GLUT5 represents a high capacity fructose transporter [2], whereas GLUT7 does not transport fructose and its physiological substrate remains unknown [9]. We thus considered that the generation of chimeras of these two transporters might be a suitable model to identify amino acids and protein domains involved in fructose transport.…”
“…For all cloning procedures we used the vector pMXs with human GLUT5-GFP or GLUT7-GFP (GLUT7: NM_207420.2, GLUT5: NM_003039.2) insert as described elsewhere [9]. In the first round, we divided GLUT5 into 26 fragments covering the complete protein sequence and constructed GLUT5-GLUT7-GFP chimeras by overlap extension PCR.…”
Section: Methodsmentioning
confidence: 99%
“…Although their protein sequence is approximately 60 % identical, the transport characteristics are different. GLUT5 represents a high capacity fructose transporter [2], whereas GLUT7 does not transport fructose and its physiological substrate remains unknown [9]. We thus considered that the generation of chimeras of these two transporters might be a suitable model to identify amino acids and protein domains involved in fructose transport.…”
“…There is controversy as to whether GLUT9 may function as both a fructose and urate transporter, thus being responsible for urate reabsorption in the context of increased fructose intake. 57,58 Evidence suggests that hyperuricemia risk may be partially programmed in utero. Preeclampsia is associated with increased maternal and fetal SUA levels, believed to occur secondary to endothelial dysfunction and reduced glomerular filtration rate (GFR).…”
Hyperuricemia has long been recognized to be associated with increased cardiovascular risk, including risk of developing hypertension. Epidemiological findings suggest that the link with hypertension is stronger in children and adolescents. Uric acid acts as a strong antioxidant compound in the extracellular environment but has pro-inflammatory effects within the intracellular setting. A chronic phase of microvascular injury is known to occur after prolonged periods of hyperuricemia. This is proposed to contribute to afferent arteriolopathy and elevation of blood pressure that may become unresponsive to uric acid-lowering therapies over time. Studies have struggled to infer direct causality of hyperuricemia due to a vast number of confounders including body mass index. The aim of this review is to present the available data and highlight the need for large scale prospective randomized controlled trials in this area. At present, there is limited evidence to support a role for uric acid-lowering therapies in helping mitigate the risk of hypertension.
“…Glucose Transport proteins (GLUTs) are a family of integral membrane proteins that participate in the facilitated diffusion of pentose and hexose sugars. Most mammalian cells express at least one isoform of these proteins, and often also have lower levels of one or more of the remaining 13 isoforms . GLUT2 is classically described as a facilitative transporter located on the basolateral membrane of absorptive small intestinal epithelial cells.…”
Section: Absorption Of Glucose In the Gastrointestinal Tractmentioning
Starch provides a large proportion of the dietary energy consumed worldwide. The breakdown of dietary starch is driven by α-amylase produced by the salivary glands and pancreatic acini and is completed by a range of brushborder bound enzymes. This enzymatic digestion is aided by mechanical and secretory actions of the gastrointestinal tract. The absorption of the resultant glucose in the small intestine is primarily driven by two separate transport proteins À SGLT1 and GLUT2. The control of processes that govern starch digestion is complex and still not fully understood, although it appears that the human gut has the ability to sense both glucose and non-sweet glucose oligomers. Recent work has also suggested that variations in the genes encoding for α-amylase also appear to be associated with health outcomes. The authors consider the physiological factors that govern starch digestion and absorption, consider other dietary factors that may impact on this process and attempt to highlight the limitations in current knowledge to help focus future research needs in relation to starch digestion the upper gastrointestinal tract.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.